CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 139 filers reported holding CHINOOK THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,502,452 | +72.0% | 39,106 | +3.6% | 0.00% | – |
| Q1 2023 | $873,634 | -84.0% | 37,738 | -81.9% | 0.00% | -100.0% |
| Q4 2022 | $5,463,538 | +42.5% | 208,532 | +6.9% | 0.00% | +100.0% |
| Q3 2022 | $3,835,000 | -36.7% | 195,110 | -43.7% | 0.00% | -50.0% |
| Q2 2022 | $6,063,000 | +1098.2% | 346,654 | +1021.9% | 0.00% | – |
| Q1 2022 | $506,000 | +181.1% | 30,899 | +179.7% | 0.00% | – |
| Q4 2021 | $180,000 | +17.6% | 11,047 | -7.9% | 0.00% | – |
| Q3 2021 | $153,000 | +3.4% | 11,992 | +14.4% | 0.00% | – |
| Q2 2021 | $148,000 | – | 10,480 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parallel Advisors, LLC | 5 | $0 | 0.00% |